Alternative Data for Becton Dickinson and Co
About Becton Dickinson and Co
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
| Price | $203.40 |
| Target Price | Sign up |
| Volume | 1,830,000 |
| Market Cap | $57.6B |
| Year Range | $166.55 - $208.35 |
| Dividend Yield | 2.02% |
| PE Ratio | 34.73 |
| Analyst Rating | 83% buy |
| Industry | Medical Devices |
In the news
 |
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-TermJanuary 25 - Yahoo |
|
BD and Ypsomed’s Large‑Volume Biologic Autoinjector Collaboration Could Be A Game Changer For Becton Dickinson (BDX)January 22 - Yahoo |
|
Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi‑Year Share Price DeclinesJanuary 13 - Yahoo |
|
Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation PlansJanuary 13 - Yahoo |
|
Despite delivering investors losses of 14% over the past 5 years, Becton Dickinson (NYSE:BDX) has been growing its earningsJanuary 7 - Yahoo |
|
RBC Sees Durable Growth Profile at Becton Dickinson (BDX), Raises TargetJanuary 2 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 5.89B | 3.09B | 2.8B | 493M | 0 | 3.960 |
| Q2 '25 | 5.89B | 3.09B | 2.8B | 493M | 1.29B | 3.680 |
| Q1 '25 | 5.27B | 3.02B | 2.26B | 308M | 1.12B | 3.350 |
| Q4 '24 | 5.17B | 2.93B | 2.24B | 303M | 1.07B | 3.430 |
| Q3 '24 | 5.44B | 2.92B | 2.52B | 421M | 1.14B | 3.810 |
Insider Transactions View All
| Garrison Michael David filed to sell 13,105 shares at $209. January 16 '26 |
| Garrison Michael David filed to sell 12,095 shares at $206.5. January 16 '26 |
| Feld Michael filed to sell 16,506 shares at $196.1. December 29 '25 |
| Garrison Michael David filed to sell 13,105 shares at $196. December 17 '25 |
| Feld Michael filed to sell 16,580 shares at $193.4. December 2 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
| Thomas H. Kean |
Jun 18, 25 | Buy | $1K - $15K |
| Rob Bresnahan |
Jun 10, 25 | Buy | $1K - $15K |
Read more about Becton Dickinson and Co (BDX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Becton Dickinson and Co
The Market Cap of Becton Dickinson and Co is $57.6B.
As of today, Becton Dickinson and Co's PE (Price to Earnings) ratio is 34.73.
Currently, the price of one share of Becton Dickinson and Co stock is $203.40.
The BDX stock price chart above provides a comprehensive visual representation of Becton Dickinson and Co's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Becton Dickinson and Co shares. Our platform offers an up-to-date BDX stock price chart, along with technical data analysis and alternative data insights.
Yes, Becton Dickinson and Co (BDX) offers dividends to its shareholders, with a dividend yield of 2.02%. This dividend yield represents Becton Dickinson and Co's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Becton Dickinson and Co in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Becton Dickinson and Co are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
